Sarfaraz Hasni, M.D.
https://www.niams.nih.gov/about/directory/sarfaraz-hasni-md
Dr. Sarfaraz Hasni is a clinician, a faculty of the Rheumatology Fellowship Training Program and chief of Lupus clinical trials.
Displaying 241 - 260 of 1017 results
Kathy Salaita, Sc.D.
https://www.niams.nih.gov/about/directory/kathy-salaita-scd
Kathy Salaita, Sc.D., is Chief of the Scientific Review Branch, and she is responsible for the supervisory management and oversight of the Scientific Review Branch and strategic planning activities as relevant to the peer review process.
Director’s Message
https://www.niams.nih.gov/about/strategic-plan-fiscal-years-2025-2029/directors-message
The NIAMS Strategic Plan for FY 2025–2029 focuses on advancing therapy, fostering discoveries, supporting research infrastructure, and communicating health advances from the Director.
Strategic Plan Framework
https://www.niams.nih.gov/about/strategic-plan-fiscal-years-2025-2029/strategic-plan-framework
NIAMS Strategic Plan FY 2025–2029 advances research in arthritis, musculoskeletal, and skin diseases, focusing on innovation, equity, collaboration, and workforce diversity.
Introduction
https://www.niams.nih.gov/about/strategic-plan-fiscal-years-2025-2029/introduction
NIAMS, established in 1986, supports research on arthritis, musculoskeletal, and skin diseases, aiming for transformative research and equitable health outcomes.
Bold Aspirations
https://www.niams.nih.gov/about/strategic-plan-fiscal-years-2025-2029/introduction/bold-aspirations
NIAMS aims for advances in disease understanding, personalized treatments, data science, digital health, and addressing health disparities over the next five years.
Organizational Structure
NIAMS, part of NIH, supports research on arthritis, musculoskeletal, and skin diseases through extramural and intramural programs, advancing health via innovative treatments.
Approach to Priority Setting
The NIAMS FY 2025–2029 Plan outlines 4 goals, 10 priorities, and a commitment to equitable research and workforce support to improve human health outcomes.
Strategic Goals and Priorities
https://www.niams.nih.gov/about/strategic-plan-fiscal-years-2025-2029/strategic-goals-priorities
NIAMS focuses on advancing therapies, fostering discoveries, supporting research infrastructure, and sharing breakthroughs to improve health in its mission areas.
Research Priorities
NIAMS encourages creative research on arthritis, musculoskeletal, and skin diseases, offering resources and priorities for scientists and collaborators to explore.
Priority 1: Studying Molecular and Cellular Mechanisms of Health and Disease in Humans and Understanding the Resulting Phenotypes and Endotypes
NIAMS supports research into molecular and cellular processes to understand disease mechanisms, including the role of sex differences and interactions in health and disease.
Priority 2: Developing Regenerative Medicine Approaches to Facilitate Repair or Restoration of Tissue
Regenerative medicine uses stem cells, biomaterials, and gene editing to restore musculoskeletal and skin tissues, with NIAMS advancing research and clinical applications.
Priority 3: Using Data Science, Artificial Intelligence and Machine Learning (AI/ML), and Computational Biology to Advance Knowledge and Treatments
NIAMS leverages AI/ML and data science to improve treatments, foster collaborations, ensure data stewardship, and advance patient-specific research and tools.
Priority 4: Understanding Behaviors and Environmental Exposures That Promote Health or Cause Disease
NIAMS explores how behaviors, environment, and the exposome affect disease onset, severity, and treatment, aiming to reduce health disparities and improve outcomes.
Priority 5: Translating Findings Into Interventions Through Clinical and Epidemiologic Studies
NIAMS focuses on translating discoveries into patient care, emphasizing equitable, innovative clinical trials, precision medicine, and strategies to reduce health disparities.
Priority 6: Conducting Research to Address Health Disparities
NIAMS aims to reduce health disparities.
Capacity-Building Priorities
NIAMS highlights community-identified needs, priorities, and resources to advance arthritis, musculoskeletal, and skin disease research and treatments.
Priority 7: Developing Enabling Research Infrastructure Including Technologies and Model Systems
NIAMS fosters biomedical innovation by supporting advanced models, diagnostic tools, and technologies to improve research and patient care in bone, joint, muscle, and skin diseases.